{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:46:08Z","timestamp":1768715168248,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01558"],"award-info":[{"award-number":["2023J01558"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microchim Acta"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00604-025-07230-w","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T01:17:34Z","timestamp":1747963054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Smartphone-assisted portable immunosensor toward on-site detection of tumor necrosis factor-\u03b1 inhibitor adalimumab for personalized treatment"],"prefix":"10.1007","volume":"192","author":[{"given":"Yun-Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Wen","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruo-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"1","key":"7230_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/tcrm.2007.3.1.133","volume":"3","author":"PJ Mease","year":"2007","unstructured":"Mease PJ (2007) Adalimumab in the treatment of arthritis. Ther Clin Risk Manag 3(1):133\u2013148. https:\/\/doi.org\/10.2147\/tcrm.2007.3.1.133","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"7230_CR2","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"J Di","year":"2021","unstructured":"Di J, Lee AH, Shin HY, Song HR, Park JH, Kang TB, Lee SR, Yang SH (2021) The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci 22(5):2719. https:\/\/doi.org\/10.3390\/ijms22052719","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7230_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214(2):149\u2013160. https:\/\/doi.org\/10.1002\/path.2287","journal-title":"J Pathol"},{"issue":"4","key":"7230_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1517\/14740338.4.4.637","volume":"4","author":"N Scheinfeld","year":"2005","unstructured":"Scheinfeld N (2005) Adalimumab: a review of side effects. Expert Opin Drug Saf 4(4):637\u2013641. https:\/\/doi.org\/10.1517\/14740338.4.4.637","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"7230_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/thoraxjnl-2011-200590","volume":"67","author":"S Bertok","year":"2012","unstructured":"Bertok S, Wilson MR, Morley PJ, de Wildt R, Bayliffe A, Takata M (2012) Selective inhibition of intra-alveolar p55 TNF receptor attenuates ventilator-induced lung injury. Thorax 67(3):244\u2013251. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200590","journal-title":"Thorax"},{"issue":"5","key":"7230_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2125.2008.03263.x","volume":"66","author":"P Traczewski","year":"2008","unstructured":"Traczewski P, Rudnicka L (2008) Adalimumab in dermatology. Br J Clin Pharmacol 66(5):618\u2013625. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03263.x","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"7230_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cgh.2012.06.032","volume":"10","author":"I Ordas","year":"2012","unstructured":"Ordas I, Feagan BG, Sandborn WJ (2012) Therapeutic drug monitoring of tumor necrosis factor antagonists in inflammatory bowel disease. Clin Gastroenterol Hepatol 10(10):1079\u20131087. https:\/\/doi.org\/10.1016\/j.cgh.2012.06.032","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"7230_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12865-021-00473-1","volume":"22","author":"F Francois","year":"2021","unstructured":"Francois F, Naimi L, Roblin X, Berger AE, Paul S (2021) Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501). BMC Immunol 22(1):81. https:\/\/doi.org\/10.1186\/s12865-021-00473-1","journal-title":"BMC Immunol"},{"issue":"5","key":"7230_CR9","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1053\/j.gastro.2009.07.062","volume":"137","author":"K Karmiris","year":"2009","unstructured":"Karmiris K, Paintaud G, Noman M, Magdelaine-Beuzelin C, Ferrante M, Degenne D, Claes K, Coopman T, Van Schuerbeek N, Van Assche G, Vermeire S, Rutgeerts P (2009) Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn\u2019s disease. Gastroenterology 137(5):1628\u20131640. https:\/\/doi.org\/10.1053\/j.gastro.2009.07.062","journal-title":"Gastroenterology"},{"issue":"4","key":"7230_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ajg.2011.60","volume":"106","author":"V Billioud","year":"2011","unstructured":"Billioud V, Sandborn WJ, Peyrin-Biroulet L (2011) Loss of response and need for adalimumab dose intensification in Crohn\u2019s disease: a systematic review. Am J Gastroenterol 106(4):674\u2013684. https:\/\/doi.org\/10.1038\/ajg.2011.60","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"7230_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","volume":"38","author":"HC Ates","year":"2020","unstructured":"Ates HC, Roberts JA, Lipman J, Cass AEG, Urban GA, Dincer C (2020) On-site therapeutic drug monitoring. Trends Biotechnol 38(11):1262\u20131277. https:\/\/doi.org\/10.1016\/j.tibtech.2020.03.001","journal-title":"Trends Biotechnol"},{"issue":"11\u201312","key":"7230_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/apt.14368","volume":"46","author":"N Mitrev","year":"2017","unstructured":"Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW (2017) Review article: Consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Aliment Pharmacol Ther 46(11\u201312):1037\u20131053. https:\/\/doi.org\/10.1111\/apt.14368","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"7230_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2017.07.032","volume":"153","author":"JD Feuerstein","year":"2017","unstructured":"Feuerstein JD, Nguyen GC, Kupfer SS, Falck-Ytter Y, Singh S, American Gastroenterological Association Institute Clinical Guidelines C (2017) American gastroenterological association institute guideline on therapeutic drug monitoring in inflammatory bowel disease. Gastroenterology 153(3):827\u2013834. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.032","journal-title":"Gastroenterology"},{"issue":"2","key":"7230_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/acr.21798","volume":"65","author":"L-H Chu","year":"2013","unstructured":"Chu L-H, Portugal C, Kawatkar AA, Stohl W, Nichol MB (2013) Racial\/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res 65(2):299\u2013303. https:\/\/doi.org\/10.1002\/acr.21798","journal-title":"Arthritis Care Res"},{"issue":"3","key":"7230_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s40744-021-00345-5","volume":"8","author":"C Gomez-Arango","year":"2021","unstructured":"Gomez-Arango C, Gorostiza I, Ucar E, Garcia-Vivar ML, Perez CE, De Dios JR, Alvarez B, Ruibal-Escribano A, Stoye C, Vasques M, Belzunegui J, Escobar A, Trancho Z, Del Agua AR, Del Rio L, Jorquera C, Diez E, Martinez A, Nagore D (2021) Cost-effectiveness of therapeutic drug monitoring-guided adalimumab therapy in rheumatic diseases: a prospective, pragmatic trial. Rheumatol Ther 8(3):1323\u20131339. https:\/\/doi.org\/10.1007\/s40744-021-00345-5","journal-title":"Rheumatol Ther"},{"key":"7230_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.aca.2019.03.033","volume":"1067","author":"T Willeman","year":"2019","unstructured":"Willeman T, Jourdil JF, Gautier-Veyret E, Bonaz B, Stanke-Labesque F (2019) A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn\u2019s disease. Anal Chim Acta 1067:63\u201370. https:\/\/doi.org\/10.1016\/j.aca.2019.03.033","journal-title":"Anal Chim Acta"},{"key":"7230_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpba.2013.01.031","volume":"78\u201379","author":"SL Wang","year":"2013","unstructured":"Wang SL, Hauenstein S, Ohrmund L, Shringarpure R, Salbato J, Reddy R, McCowen K, Shah S, Lockton S, Chuang E, Singh S (2013) Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay. J Pharm Biomed Anal 78\u201379:39\u201344. https:\/\/doi.org\/10.1016\/j.jpba.2013.01.031","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"7230_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/ard.2008.092833","volume":"68","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, van Riel PL, Bendtzen K (2009) Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. Ann Rheum Dis 68(11):1739\u20131745. https:\/\/doi.org\/10.1136\/ard.2008.092833","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7230_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/dta.2250","volume":"10","author":"S Bian","year":"2018","unstructured":"Bian S, Lu J, Delport F, Vermeire S, Spasic D, Lammertyn J, Gils A (2018) Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn\u2019s disease. Drug Test Anal 10(3):592\u2013596. https:\/\/doi.org\/10.1002\/dta.2250","journal-title":"Drug Test Anal"},{"issue":"10","key":"7230_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.4155\/bio.15.30","volume":"7","author":"C Desvignes","year":"2015","unstructured":"Desvignes C, Edupuganti SR, Darrouzain F, Duveau AC, Loercher A, Paintaud G, Mulleman D (2015) Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration. Bioanalysis 7(10):1253\u20131260. https:\/\/doi.org\/10.4155\/bio.15.30","journal-title":"Bioanalysis"},{"issue":"2","key":"7230_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3343\/alm.2022.42.2.121","volume":"42","author":"BA Rappold","year":"2022","unstructured":"Rappold BA (2022) Review of the use of liquid chromatography-tandem mass spectrometry in clinical laboratories: Part I-development. Ann Lab Med 42(2):121\u2013140. https:\/\/doi.org\/10.3343\/alm.2022.42.2.121","journal-title":"Ann Lab Med"},{"issue":"4","key":"7230_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.pathol.2022.08.013","volume":"55","author":"KL Chow","year":"2023","unstructured":"Chow KL, Keating PE, O\u2019Donnell JL (2023) Subtyping anti-infliximab antibodies by the homogenous mobility shift assay (HMSA): potential utility in a pharmacokinetic case study. Pathology 55(4):587\u2013590. https:\/\/doi.org\/10.1016\/j.pathol.2022.08.013","journal-title":"Pathology"},{"key":"7230_CR23","doi-asserted-by":"publisher","first-page":"113748","DOI":"10.1016\/j.jim.2024.113748","volume":"534","author":"A Mariscal","year":"2024","unstructured":"Mariscal A, Martinez C, Goethals L, Cortes-Vicente E, Molto E, Juarez C, Barneda-Zahonero B, Querol L, Le Panse R, Gallardo E (2024) Modified radioimmunoassay versus ELISA to quantify anti-acetylcholine receptor antibodies in a mouse model of myasthenia gravis. J Immunol Methods 534:113748. https:\/\/doi.org\/10.1016\/j.jim.2024.113748","journal-title":"J Immunol Methods"},{"issue":"1","key":"7230_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12026-016-8824-8","volume":"65","author":"M Ogric","year":"2017","unstructured":"Ogric M, Tercelj M, Praprotnik S, Tomsic M, Bozic B, Sodin-Semrl S, Cucnik S (2017) Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits. Immunol Res 65(1):172\u2013185. https:\/\/doi.org\/10.1007\/s12026-016-8824-8","journal-title":"Immunol Res"},{"issue":"5","key":"7230_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/FTD.0000000000001095","volume":"45","author":"K Papamichael","year":"2023","unstructured":"Papamichael K, Stocco G, Ruiz Del Agua A (2023) Challenges in therapeutic drug monitoring: optimizing biological treatments in patients with inflammatory bowel disease and other immune-mediated inflammatory diseases. Ther Drug Monit 45(5):579\u2013590. https:\/\/doi.org\/10.1097\/FTD.0000000000001095","journal-title":"Ther Drug Monit"},{"issue":"6","key":"7230_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.trac.2011.01.019","volume":"30","author":"PB Luppa","year":"2011","unstructured":"Luppa PB, Muller C, Schlichtiger A, Schlebusch H (2011) Point-of-care testing (POCT): Current techniques and future perspectives. Trends Analyt Chem 30(6):887\u2013898. https:\/\/doi.org\/10.1016\/j.trac.2011.01.019","journal-title":"Trends Analyt Chem"},{"issue":"16","key":"7230_CR27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1039\/c7lc00397h","volume":"17","author":"HN Chan","year":"2017","unstructured":"Chan HN, Tan MJA, Wu H (2017) Point-of-care testing: applications of 3D printing. Lab Chip 17(16):2713\u20132739. https:\/\/doi.org\/10.1039\/c7lc00397h","journal-title":"Lab Chip"},{"issue":"10","key":"7230_CR28","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1373\/clinchem.2018.287052","volume":"64","author":"P Wang","year":"2018","unstructured":"Wang P, Kricka LJ (2018) Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation. Clin Chem 64(10):1439\u20131452. https:\/\/doi.org\/10.1373\/clinchem.2018.287052","journal-title":"Clin Chem"},{"issue":"4","key":"7230_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/elan.200503415","volume":"18","author":"X Luo","year":"2006","unstructured":"Luo X, Morrin A, Killard AJ, Smyth MR (2006) Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 18(4):319\u2013326. https:\/\/doi.org\/10.1002\/elan.200503415","journal-title":"Electroanalysis"},{"issue":"2","key":"7230_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.aca.2007.07.054","volume":"598","author":"S Guo","year":"2007","unstructured":"Guo S, Wang E (2007) Synthesis and electrochemical applications of gold nanoparticles. Anal Chim Acta 598(2):181\u2013192. https:\/\/doi.org\/10.1016\/j.aca.2007.07.054","journal-title":"Anal Chim Acta"},{"issue":"Pt 1","key":"7230_CR31","doi-asserted-by":"publisher","first-page":"125280","DOI":"10.1016\/j.talanta.2023.125280","volume":"268","author":"G Siciliano","year":"2024","unstructured":"Siciliano G, Alsadig A, Chiriaco MS, Turco A, Foscarini A, Ferrara F, Gigli G, Primiceri E (2024) Beyond traditional biosensors: Recent advances in gold nanoparticles modified electrodes for biosensing applications. Talanta 268(Pt 1):125280. https:\/\/doi.org\/10.1016\/j.talanta.2023.125280","journal-title":"Talanta"},{"issue":"1","key":"7230_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/bios13010125","volume":"13","author":"AV Police Patil","year":"2023","unstructured":"Police Patil AV, Chuang YS, Li C, Wu CC (2023) Recent advances in electrochemical immunosensors with nanomaterial assistance for signal amplification. Biosensors (Basel) 13(1):125. https:\/\/doi.org\/10.3390\/bios13010125","journal-title":"Biosensors (Basel)"},{"issue":"3","key":"7230_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2174\/187221008786369651","volume":"2","author":"BI Kharisov","year":"2008","unstructured":"Kharisov BI (2008) A review for synthesis of nanoflowers. Recent Pat Nanotechnol 2(3):190\u2013200. https:\/\/doi.org\/10.2174\/187221008786369651","journal-title":"Recent Pat Nanotechnol"},{"issue":"sup1","key":"7230_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/21691401.2018.1428812","volume":"46","author":"P Shende","year":"2018","unstructured":"Shende P, Kasture P, Gaud RS (2018) Nanoflowers: The future trend of nanotechnology for multi-applications. Artif Cells Nanomed Biotechnol 46(sup1):413\u2013422. https:\/\/doi.org\/10.1080\/21691401.2018.1428812","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"21","key":"7230_CR35","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.3390\/s21217098","volume":"21","author":"NA Taranova","year":"2021","unstructured":"Taranova NA, Byzova NA, Pridvorova SM, Zherdev AV, Dzantiev BB (2021) Comparative assessment of different gold nanoflowers as labels for lateral flow immunosensors. Sensors 21(21):7098. https:\/\/doi.org\/10.3390\/s21217098","journal-title":"Sensors"},{"issue":"8","key":"7230_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00604-023-05878-w","volume":"190","author":"H Wei","year":"2023","unstructured":"Wei H, Sun B, Li Y, Wang Y, Chen Y, Guo M, Mo X, Hu F, Du Y (2023) Electrochemical immunosensor AuNPs\/NG-PANI\/ITO-PET for the determination of BDNF in depressed mice serum. Mikrochim Acta 190(8):330. https:\/\/doi.org\/10.1007\/s00604-023-05878-w","journal-title":"Mikrochim Acta"},{"issue":"24","key":"7230_CR37","doi-asserted-by":"publisher","first-page":"9938","DOI":"10.3390\/s22249938","volume":"22","author":"HW Chang","year":"2022","unstructured":"Chang HW, Chen CL, Chen YH, Chang YM, Liu FJ, Tsai YC (2022) Electrochemical organophosphorus pesticide detection using nanostructured gold-modified electrodes. Sensors (Basel) 22(24):9938. https:\/\/doi.org\/10.3390\/s22249938","journal-title":"Sensors (Basel)"},{"key":"7230_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.talanta.2018.10.080","volume":"194","author":"W Zhang","year":"2019","unstructured":"Zhang W, Duan H, Chen R, Ma T, Zeng L, Leng Y, Xiong Y (2019) Effect of different-sized gold nanoflowers on the detection performance of immunochromatographic assay for human chorionic gonadotropin detection. Talanta 194:604\u2013610. https:\/\/doi.org\/10.1016\/j.talanta.2018.10.080","journal-title":"Talanta"},{"key":"7230_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41378-021-00258-x","volume":"7","author":"D Feng","year":"2021","unstructured":"Feng D, Su J, Xu Y, He G, Wang C, Wang X, Pan T, Ding X, Mi X (2021) DNA tetrahedron-mediated immune-sandwich assay for rapid and sensitive detection of PSA through a microfluidic electrochemical detection system. Microsyst Nanoeng 7:33. https:\/\/doi.org\/10.1038\/s41378-021-00258-x","journal-title":"Microsyst Nanoeng"},{"key":"7230_CR40","doi-asserted-by":"publisher","first-page":"115001","DOI":"10.1016\/j.bios.2022.115001","volume":"222","author":"TC Lu","year":"2023","unstructured":"Lu TC, Sun YM, Zhong Y, Lin XH, Lei Y, Liu AL (2023) Electrochemical immunosensor based on AuNPs\/ERGO@CNT nanocomposites by one-step electrochemical co-reduction for sensitive detection of P-glycoprotein in serum. Biosens Bioelectron 222:115001. https:\/\/doi.org\/10.1016\/j.bios.2022.115001","journal-title":"Biosens Bioelectron"},{"issue":"5","key":"7230_CR41","doi-asserted-by":"publisher","first-page":"130356","DOI":"10.1016\/j.snb.2021.130356","volume":"345","author":"RR Mustafa","year":"2021","unstructured":"Mustafa RR, Sukor R, Eissa S, Shahrom AN, Nor SMM (2021) Sensitive detection of mitragynine from Mitragyna speciosa Korth using an electrochemical immunosensor based on multiwalled carbon nanotubes\/chitosan- modified carbon electrode. Sens Actuators B Chem 345(5):130356. https:\/\/doi.org\/10.1016\/j.snb.2021.130356","journal-title":"Sens Actuators B Chem"},{"issue":"2","key":"7230_CR42","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1021\/acsnano.7b07460","volume":"12","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Koh HJ, Ren CE, Kwon O, Maleski K, Cho SY, Anasori B, Kim CK, Choi YK, Kim J, Gogotsi Y, Jung HT (2018) Metallic Ti(3)C(2)T(x) MXene gas sensors with ultrahigh signal-to-noise ratio. ACS Nano 12(2):986\u2013993. https:\/\/doi.org\/10.1021\/acsnano.7b07460","journal-title":"ACS Nano"},{"issue":"20","key":"7230_CR43","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.3390\/s23208532","volume":"23","author":"D Lapsa","year":"2023","unstructured":"Lapsa D, Janeliukstis R, Elsts A (2023) Adaptive signal-to-noise ratio indicator for wearable bioimpedance monitoring. Sensors 23(20):8532. https:\/\/doi.org\/10.3390\/s23208532","journal-title":"Sensors"},{"key":"7230_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bios.2019.01.068","volume":"132","author":"J Liu","year":"2019","unstructured":"Liu J, Geng Z, Fan Z, Liu J, Chen H (2019) Point-of-care testing based on smartphone: The current state-of-the-art (2017\u20132018). Biosens Bioelectron 132:17\u201337. https:\/\/doi.org\/10.1016\/j.bios.2019.01.068","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"7230_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13206-020-4104-8","volume":"14","author":"YD Han","year":"2020","unstructured":"Han YD, Chun HJ, Yoon HC (2020) Low-cost point-of-care biosensors using common electronic components as transducers. BioChip J 14(1):32\u201347. https:\/\/doi.org\/10.1007\/s13206-020-4104-8","journal-title":"BioChip J"},{"key":"7230_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpba.2016.03.029","volume":"125","author":"S Bian","year":"2016","unstructured":"Bian S, Stappen TV, Baert F, Compernolle G, Brouwers E, Tops S, de Vries A, Rispens T, Lammertyn J, Vermeire S, Gils A (2016) Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays. J Pharm Biomed Anal 125:62\u201367. https:\/\/doi.org\/10.1016\/j.jpba.2016.03.029","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"7230_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/FTD.0000000000000229","volume":"38","author":"BD Hock","year":"2016","unstructured":"Hock BD, Stamp LK, Hayman MW, Keating PE, Helms ET, Barclay ML (2016) Development of an ELISA-based competitive binding assay for the analysis of drug concentration and antidrug antibody levels in patients receiving adalimumab or infliximab. Ther Drug Monit 38(1):32\u201341. https:\/\/doi.org\/10.1097\/FTD.0000000000000229","journal-title":"Ther Drug Monit"},{"key":"7230_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.cca.2018.05.015","volume":"483","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wysocki E, Antwi K, Niederkofler E, Leung EKY, Lazar-Molnar E, Yeo KTJ (2018) Development and validation of a targeted affinity-enrichment and LC-MS\/MS proteomics approach for the therapeutic monitoring of adalimumab. Clin Chim Acta 483:308\u2013314. https:\/\/doi.org\/10.1016\/j.cca.2018.05.015","journal-title":"Clin Chim Acta"},{"key":"7230_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114125","volume":"206","author":"JH Qu","year":"2022","unstructured":"Qu JH, Ordutowski H, Van Tricht C, Verbruggen R, Barcenas Gallardo A, Bulcaen M, Ciwinska M, Cisneros CG, Devriese C, Guluzade S, Janssens X, Kornblum S, Lu Y, Marolt N, Nanjappan C, Rutten E, Vanhauwaert E, Geukens N, Thomas D, Dosso FD, Safdar S, Spasic D, Lammertyn J (2022) Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge. Biosens Bioelectron 206:114125. https:\/\/doi.org\/10.1016\/j.bios.2022.114125","journal-title":"Biosens Bioelectron"},{"key":"7230_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelechem.2019.113381","volume":"849","author":"MJ Lin","year":"2019","unstructured":"Lin MJ, Chen YM, Li CZ, Wu CC (2019) Electrochemical sandwich immunoassay for quantification of therapeutic drugs based on the use of magnetic nanoparticles and silica nanoparticles. J Electroanal Chem 849:113381. https:\/\/doi.org\/10.1016\/j.jelechem.2019.113381","journal-title":"J Electroanal Chem"},{"issue":"6","key":"7230_CR51","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1039\/d3sd00131h","volume":"2","author":"EA van Aalen","year":"2023","unstructured":"van Aalen EA, de Vries IR, Hanckmann ETL, Stevens JRF, Romagnoli TR, Derijks LJJ, Broeren MAC, Merkx M (2023) Point-of-care therapeutic drug monitoring of tumour necrosis factor-alpha inhibitors using a single step immunoassay. Sens Diagn 2(6):1492\u20131500. https:\/\/doi.org\/10.1039\/d3sd00131h","journal-title":"Sens Diagn"},{"issue":"5","key":"7230_CR52","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1021\/acssensors.0c02642","volume":"6","author":"SJ Kim","year":"2021","unstructured":"Kim SJ, Dixon AS, Adamovich PC, Robinson PD, Owen SC (2021) Homogeneous immunoassay using a Tri-Part split-luciferase for rapid quantification of anti-TNF therapeutic antibodies. ACS Sens 6(5):1807\u20131814. https:\/\/doi.org\/10.1021\/acssensors.0c02642","journal-title":"ACS Sens"}],"container-title":["Microchimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-025-07230-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00604-025-07230-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-025-07230-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:54:56Z","timestamp":1749545696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00604-025-07230-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7230"],"URL":"https:\/\/doi.org\/10.1007\/s00604-025-07230-w","relation":{},"ISSN":["0026-3672","1436-5073"],"issn-type":[{"value":"0026-3672","type":"print"},{"value":"1436-5073","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research is conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"366"}}